Evogene Ltd. - stock earnings
EVGN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -6.6 million USD | 578000 USD |
| 2023Q3 | -4.0 million USD | 3.8 million USD |
| 2023Q2 | -7.0 million USD | 654000 USD |
| 2023Q1 | -7.0 million USD | 641000 USD |
| 2022Q4 | -3.8 million USD | 660000 USD |
| 2022Q3 | -7.2 million USD | 466000 USD |
| 2022Q2 | -9.8 million USD | 312000 USD |
| 2022Q1 | -9.1 million USD | 237000 USD |
| 2021Q4 | -7.4 million USD | 311000 USD |
| 2021Q3 | -7.6 million USD | 151000 USD |
| 2021Q2 | -6.2 million USD | 135000 USD |
| 2021Q1 | -8.1 million USD | 351000 USD |
| 2020Q4 | -8.1 million USD | 351000 USD |
| 2020Q3 | -4.8 million USD | 316000 USD |
| 2020Q2 | -4.2 million USD | 298000 USD |
| 2020Q1 | -6.1 million USD | 116000 USD |
| 2019Q4 | -6.1 million USD | 116000 USD |
| 2019Q3 | -4.2 million USD | 97000 USD |
| 2019Q2 | -4.1 million USD | 192000 USD |
| 2019Q1 | -5.8 million USD | 635000 USD |
| 2018Q4 | -5.8 million USD | 635000 USD |
| 2018Q3 | -4.8 million USD | 367000 USD |
| 2018Q2 | -4.8 million USD | 379000 USD |
| 2018Q1 | -5.4 million USD | 366000 USD |
| 2017Q4 | -6.2 million USD | 734000 USD |
| 2017Q3 | -5.0 million USD | 748000 USD |
| 2017Q2 | -4.7 million USD | 1.2 million USD |
| 2017Q1 | -6.6 million USD | 1.2 million USD |
| 2016Q4 | -6.6 million USD | 1.2 million USD |
| 2016Q3 | -5.1 million USD | 1.5 million USD |
| 2016Q2 | -4.5 million USD | 1.8 million USD |
| 2016Q1 | -5.5 million USD | 2.5 million USD |
| 2015Q4 | -5.5 million USD | 2.5 million USD |
| 2015Q3 | -3.4 million USD | 3.3 million USD |
| 2015Q2 | -5.0 million USD | 2.7 million USD |
| 2015Q1 | -4.8 million USD | 3.6 million USD |
| 2014Q4 | -4.8 million USD | 3.6 million USD |
| 2014Q3 | -4.2 million USD | 3.2 million USD |
| 2014Q2 | -3.2 million USD | 3.9 million USD |
| 2014Q1 | -4.2 million USD | 4.4 million USD |
| 2013Q4 | -4.2 million USD | 4.4 million USD |
| 2013Q3 | -2.3 million USD | 4.2 million USD |
| 2013Q2 | -1.9 million USD | 4.3 million USD |
| 2013Q1 | -481000 USD | 4.6 million USD |
| 2012Q4 | -765000 USD | 4.8 million USD |
| 2012Q3 | -1.0 million USD | 4.0 million USD |
| 2012Q2 | -1.2 million USD | 4.1 million USD |
| 2011Q4 | 645000 USD | 14.9 million USD |
EVGN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -23.9 million USD | 5.6 million USD |
| 2022 | -29.8 million USD | 1.7 million USD |
| 2021 | -30.4 million USD | 930000 USD |
| 2020 | -26.2 million USD | 1.0 million USD |
| 2019 | -19.1 million USD | 753000 USD |
| 2018 | -20.8 million USD | 1.7 million USD |
| 2017 | -20.8 million USD | 3.4 million USD |
| 2016 | -19.6 million USD | 6.5 million USD |
| 2015 | -17.2 million USD | 11.1 million USD |
| 2014 | -14.5 million USD | 14.5 million USD |
| 2013 | -8.9 million USD | 17.6 million USD |
| 2012 | -2.5 million USD | 17.1 million USD |
| 2011 | 645000 USD | 14.9 million USD |
EVGN
Price: $0.71
52 week price:
Earnings Per Share: -0.52 USD
P/E Ratio: -1.62
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 71621
Ebitda: -8.5 millionMarket Capitalization: 38.7 million